On 26 January, the U.S. Food and Drug Administration (FDA) announced its approval of the first radiopharmaceutical — a drug that contains a radioactive substance — for the treatment of GEP-NETS, a rare group of digestive tract cancers.
“The powers not delegated to the United States by the Constitution, nor prohibited by it to the States, […]
Health care policies are implemented through expenditure decisions made by government officials. Today, a federal court deemed a lawsuit […]
Yesterday (6 Dec), the House passed H.R. 38. The bill amends chapter 44, title 18 of the United […]
In FY 2016, total Medicaid Expenditures — including the US Territories, administrative costs, and accounting adjustments — exceeded $574 […]
Yale Law School’s Rule of Law Clinic is representing the National Association for the Advancement of Colored People […]
QUANTIFYING THE IMPACT OF SOCIAL DETERMINANTS OF HEALTH At the US News Healthcare of Tomorrow Conference on Nov. […]